High Tech Pharm Co. Ltd (KQ:106190) — Market Cap & Net Worth
Market Cap & Net Worth: High Tech Pharm Co. Ltd (106190)
High Tech Pharm Co. Ltd (KQ:106190) has a market capitalization of $100.09 Million (₩147.69 Billion) as of June 17, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #19276 globally and #958 in its home market, demonstrating a 0.51% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying High Tech Pharm Co. Ltd's stock price ₩13890.00 by its total outstanding shares 10632598 (10.63 Million). Review how much debt does High Tech Pharm Co. Ltd carry to assess the company's total debt and financial obligations.
High Tech Pharm Co. Ltd Market Cap History: 2015 to 2026
High Tech Pharm Co. Ltd's market capitalization history from 2015 to 2026. Data shows growth from $67.14 Million to $100.09 Million (3.92% CAGR).
Index Memberships
High Tech Pharm Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$273.60 Billion | 0.04% | #397 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$273.60 Billion | 0.04% | #397 of 1384 |
Weight: High Tech Pharm Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
High Tech Pharm Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how High Tech Pharm Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
High Tech Pharm Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
High Tech Pharm Co. Ltd's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $67.14 Million | $48.09 Billion | $6.54 Billion | 0.00x | 0.01x |
| 2016 | $68.99 Million | $54.84 Billion | $5.28 Billion | 0.00x | 0.01x |
| 2017 | $55.13 Million | $66.05 Billion | $2.10 Billion | 0.00x | 0.03x |
| 2018 | $81.53 Million | $66.39 Billion | $2.61 Billion | 0.00x | 0.03x |
| 2019 | $53.19 Million | $63.07 Billion | -$4.22 Billion | 0.00x | N/A |
| 2020 | $87.11 Million | $74.46 Billion | -$3.15 Billion | 0.00x | N/A |
| 2021 | $64.92 Million | $73.29 Billion | -$1.23 Billion | 0.00x | N/A |
| 2022 | $51.98 Million | $102.95 Billion | $5.87 Billion | 0.00x | 0.01x |
| 2023 | $67.23 Million | $76.77 Billion | $8.08 Billion | 0.00x | 0.01x |
| 2024 | $100.88 Million | $77.51 Billion | $13.71 Billion | 0.00x | 0.01x |
Competitor Companies of 106190 by Market Capitalization
Companies near High Tech Pharm Co. Ltd in the global market cap rankings as of June 17, 2026.
Key companies related to High Tech Pharm Co. Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #561 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #624 globally with a market cap of $44.20 Billion USD ( CN¥302.05 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #561 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.22 |
| #624 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $44.20 Billion | CN¥47.35 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.60 |
High Tech Pharm Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, High Tech Pharm Co. Ltd's market cap moved from $67.14 Million to $ 100.09 Million, with a yearly change of 3.92%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩100.09 Million | +15.56% |
| 2025 | ₩86.61 Million | -14.14% |
| 2024 | ₩100.88 Million | +50.05% |
| 2023 | ₩67.23 Million | +29.33% |
| 2022 | ₩51.98 Million | -19.93% |
| 2021 | ₩64.92 Million | -25.47% |
| 2020 | ₩87.11 Million | +63.78% |
| 2019 | ₩53.19 Million | -34.76% |
| 2018 | ₩81.53 Million | +47.89% |
| 2017 | ₩55.13 Million | -20.09% |
| 2016 | ₩68.99 Million | +2.75% |
| 2015 | ₩67.14 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of High Tech Pharm Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $100.09 Million USD |
| MoneyControl | $100.09 Million USD |
| MarketWatch | $100.09 Million USD |
| marketcap.company | $100.09 Million USD |
| Reuters | $100.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About High Tech Pharm Co. Ltd
High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea.